Cargando…

The relationship between bisphosphonate use and demographic characteristics of male osteoporosis patients

INTRODUCTİON: This study aimed to investigate a number of demographic characteristics in males with osteoporosis (OP) treated with bisphosphonate and determine whether any of these measures could act as an effective indicator of medication persistence and compliance. MATERIAL AND METHOD: Among the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cevikoi, Alev, Umay, Ebru, Polat, Sevgi, Ecerkale, Oznur, Cakci, Aytul
Formato:	Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2011
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093787/ https://www.ncbi.nlm.nih.gov/pubmed/21655750 http://dx.doi.org/10.1590/S1807-59322011000400010

Ejemplares similares

The Value of Calcaneal Bone Mass Measurement Using a Dual X-Ray Laser Calscan Device in Risk Screening for Osteoporosis
por: Kayalar, Gulseren, et al.
Publicado: (2009)

Can the First Web Space Angle Be Predictive of Carpal Tunnel Syndrome?
por: UZ, Cuma, et al.
Publicado: (2019)

Short-Term Efficacy of Kinesiotaping versus Extracorporeal Shockwave Therapy for Plantar Fasciitis: A Randomized Study
por: Tezel, Nihal, et al.
Publicado: (2020)

Acupuncture plus night splint for quality of life and disability in patients with carpal tunnel syndrome: a randomized controlled trial
por: Tezel, Nihal, et al.
Publicado: (2019)

How Does Nutritional Status Affect Outcomes in Patients with Neurological Diseases?
por: GÜZEL, Şükran, et al.
Publicado: (2020)

The effect of premorbid features on post-stroke rehabilitation outcome
por: Karaahmet, Ozgur Zeliha, et al.
Publicado: (2018)

Impact of the Training on the Compliance and Persistence of Weekly Bisphosphonate Treatment in Postmenopausal Osteoporosis: A Randomized Controlled Study
por: Tüzün, Şansın, et al.
Publicado: (2013)

Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
por: Villa, Alessandro, et al.
Publicado: (2011)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Bisphosphonates adherence for treatment of osteoporosis
por: Vieira, Helena Parente, et al.
Publicado: (2013)

Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate
por: Figueiredo, Marília A., et al.
Publicado: (2020)

A reappraisal of generic bisphosphonates in osteoporosis
por: Kanis, J. A., et al.
Publicado: (2011)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

Long-term use of bisphosphonates in osteoporosis
por: Sadat-Ali, Mir, et al.
Publicado: (2017)

Long-term use of bisphosphonates in osteoporosis
por: Alwahhabi, Basmah K., et al.
Publicado: (2017)

Brachial Plexus Injuries in Adults with Traumatic Brain Injury : A Retrospective Study
por: Tezel, Nihal, et al.
Publicado: (2021)

Differences between the bisphosphonates for the prevention and treatment of osteoporosis
por: Grey, Andrew, et al.
Publicado: (2006)

Patient preference in the management of postmenopausal osteoporosis with bisphosphonates
por: Reginster, Jean-Yves, et al.
Publicado: (2006)

Physicians’ perspectives on the treatment of osteoporosis patients with bisphosphonates
por: Gu, Tao, et al.
Publicado: (2016)

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

ERT, HRT, Raloxifine, Calcitonin, or Bisphosphonates for Osteoporosis
por: Curtiss, Frederic R.
Publicado: (2003)

Influence of patient training on persistence, compliance, and tolerability of different dosing frequency regimens of bisphosphonate therapy: An observational study in Turkish patients with postmenopausal osteoporosis
por: Akarırmak, Ülkü, et al.
Publicado: (2016)

Circulating vascular endothelial growth factor concentrations in patients with postmenopausal osteoporosis
por: Senel, Kazim, et al.
Publicado: (2013)

The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
por: Pazianas, Michael, et al.
Publicado: (2010)

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis
por: Cotté, F.-E., et al.
Publicado: (2009)

Correction: Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2023)

Correction to: The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis
por: Zheng, Zaoqian, et al.
Publicado: (2020)

Factors associated with paravertebral muscle cross-sectional area in patients with chronic low back pain
por: Cankurtaran, Damla, et al.
Publicado: (2021)

Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study
por: Jakob, F, et al.
Publicado: (2012)

Effectiveness of Osteoporosis Drug in Postmenopausal Women with Spinal Compression Fracture: Combined Consecutive Therapy of Teriparatide and Raloxifene versus Bisphosphonate Single
por: Shin, Chang Jin, et al.
Publicado: (2016)

Angioedema - Our Experience Focused On Socio-Demographic, Etiological and Clinical Characteristics of the Condition and Its Management
por: Dermendjiev, Svetlan, et al.
Publicado: (2019)

Relationship between plasminogen activator inhibitor type-1 (PAI-1) gene polymorphisms and osteoporosis in Turkish women
por: Ozgen, Merih, et al.
Publicado: (2012)

Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
por: Bock, Oliver, et al.
Publicado: (2008)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
por: Dalle Carbonare, Luca, et al.
Publicado: (2010)

Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk
por: Newcomb, P A, et al.
Publicado: (2010)

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
por: Höer, Ariane, et al.
Publicado: (2009)

Bisphosphonates as treatment of secondary osteoporosis in children: a case series
por: Soesanti, Frida, et al.
Publicado: (2015)

Dose-Intensity of Bisphosphonates and the Risk of Osteonecrosis of the Jaw in Osteoporosis Patients
por: Jung, Sung-mok, et al.
Publicado: (2018)

Can Alarming Improve Compliance with Weekly Bisphosphonate in Patients with Osteoporosis?
por: Nho, Jae-Hwi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1rqr6ccq96hspstrhs4lt0kdp2